Skip to main content
. Author manuscript; available in PMC: 2021 Dec 7.
Published in final edited form as: Anticancer Res. 2020 Dec 7;40(12):6637–6647. doi: 10.21873/anticanres.14688

Figure 2.

Figure 2.

Molecular docking with NF-κB complex. Docking of (+)-betulin with PDB structures: (A) NF-κB p50 (1NFK); (B) NF-κB p52 (IA3Q); (C) NF-κB p65 (1MY5); and (D) docking of betulinic acid with NF-κB p65 (1MY5). Green dotted lines show distance and potential hydrogen bonding between NF-κB (gray) complex and (+)-betulin (cygan) ang.